Description
Flovis-150 is a clinically formulated antifungal treatment containing Fluconazole BP 150 mg in a single-dose capsule. Developed by ANVIS, this product is specifically intended for the effective management of candidiasis, commonly known as thrush, and other fungal infections affecting the mucosal membranes. Its systemic action targets the fungal cell membrane, inhibiting growth and preventing further spread within the body.
The convenience of a one-capsule regimen allows patients to complete treatment without extended dosing schedules, encouraging adherence and minimizing disruption. This is especially suitable for individuals seeking rapid symptom relief with minimal intervention. The product is recommended for adult patients and is often prescribed for vaginal candidiasis, oral thrush, and certain systemic fungal infections under medical guidance.
Flovis-150 is manufactured under stringent pharmaceutical standards to ensure safety, efficacy, and stability. Packaged in a clear blister format with a bold, professional design, it aligns with modern pharmaceutical expectations for single-use antifungal therapy.
